Asset Dedication LLC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-279
Closed -$49K 718
2020
Q1
$49K Buy
279
+246
+745% +$46.3K 0.01% 318
2019
Q4
$6K Sell
33
-87
-73% -$15.7K ﹤0.01% 532
2019
Q3
$20K Buy
120
+100
+500% +$16.3K 0.01% 391
2019
Q2
$3K Hold
20
﹤0.01% 549
2019
Q1
$3K Hold
20
﹤0.01% 574
2018
Q4
$3K Hold
20
﹤0.01% 541
2018
Q3
$4K Hold
20
﹤0.01% 546
2018
Q2
$3K Hold
20
﹤0.01% 573
2018
Q1
$3K Buy
+20
New +$3.35K ﹤0.01% 476
2016
Q4
Sell
-113
Closed -$26K 435
2016
Q3
$26K Sell
113
-10
-8% -$2.44K 0.02% 236
2016
Q2
$29K Hold
123
0.02% 219
2016
Q1
$33K Sell
123
-93
-43% -$26.6K 0.02% 208
2015
Q4
$68K Buy
+216
New +$64.3K 0.04% 210

Other funds holding AGN

Asset Dedication LLC's AGN Position: Q2 2020 in Review

Asset Dedication LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 279 shares — an estimated $49K sold.

Asset Dedication LLC first reported a position in AGN in Q4 2015 and held it in 13 quarters. The position peaked at $68K in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Asset Dedication LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Asset Dedication LLC sold 279 Allergan plc shares in Q2 2020, an estimated $49K.
  • Asset Dedication LLC first reported a position in Allergan plc in Q4 2015 and held it in 13 quarters.
  • Asset Dedication LLC's Allergan plc position peaked at $68K in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Asset Dedication LLC's 13F filing for Q2 2020, filed 24 Aug 2020.